Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-41.38	-94.67	-66.96
Graham Fair Price	-11.79	38.16	43.26
PEG	5251.90	1.06	0.02
Price/Book	12.90	3.93	3.49
Price/Cash Flow	-78.38	-62.10	287.29
Prices/Earnings	-34.41	-20.28	-15.09
Price/Sales	-11.12	43.11	48.51
Price/FCF	-78.38	-62.10	287.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.23	0.46	0.58
Operating Margin	33.97	-0.56	-0.84
ROA	13.04	-0.04	-0.05
ROE	-0.06	-0.05	16.01
ROIC	-0.04	-0.05	-12.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-1.00	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-6.98	0.19	-97.26
EPS QOQ	-7.64	0.19	-97.49
FCF QOQ	1.38	-6.04	337.00
Revenue QOQ	-0.57	0.22	-60.81
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	476.38	310.86	-34.75
Days Sales Outstanding (DSO)	30.36	27.60	-9.10
Inventory Turnover	0.19	0.29	53.25
Debt/Capitalization	0.05	0.00	inf
Quick Ratio	2.86	3.28	14.53
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.95	36.53	-3.75
Cash	13.79	10.43	-24.40
Capex	-0.12	-0.06	47.26
Free Cash Flow	0.46	-2.31	402.65
Revenue	2.73	3.33	22.25
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.51	5.80	28.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.03	4.13	36.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating